These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8781354)

  • 1. Recurrence of hepatocellular carcinoma after surgery: can it be avoided?
    Kew MC
    Hepatology; 1996 Sep; 24(3):741-2. PubMed ID: 8781354
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
    Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
    Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
    Vibert E; Samuel D
    J Hepatol; 2008 Oct; 49(4):498-501. PubMed ID: 18678433
    [No Abstract]   [Full Text] [Related]  

  • 4. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
    Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma?
    Kanmematsu T
    Hepatogastroenterology; 1996; 43(12):1404. PubMed ID: 8975938
    [No Abstract]   [Full Text] [Related]  

  • 6. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
    Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
    Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver resection and liver transplantation in hepatocellular carcinoma.
    Franco D
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S94. PubMed ID: 8986104
    [No Abstract]   [Full Text] [Related]  

  • 8. Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
    Ringe B
    Hepatology; 1997 Aug; 26(2):507-8. PubMed ID: 9252168
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (Br J Surg 2002; 89: 57-62).
    Esnaola N; Vauthey JN; Lauwers G
    Br J Surg; 2002 Jul; 89(7):939-40; author reply 940. PubMed ID: 12081752
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor?
    Schwartz M; Konstadoulakis M; Roayaie S
    Liver Transpl; 2005 May; 11(5):494-6. PubMed ID: 15838915
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
    Gugenheim J; Baldini E; Casaccia M; Ouzan D; Saint-Paul MC; Mouiel J
    Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local ablation vs. resection for the treatment of hepatocellular carcinoma.
    Kao JH; Chen DS
    Hepatology; 2006 Feb; 43(2):373. PubMed ID: 16440360
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-recurrent therapy after resection of hepatocellular].
    Shen F; Wu MC
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(41):2886-8. PubMed ID: 16324359
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse intrahepatic recurrence after resection of hepatocellular carcinoma.
    Okano A; Hajiro K; Takakuwa H; Nishio A; Matsusue S; Sano A; Kobashi Y
    Hepatogastroenterology; 2000; 47(35):1356-9. PubMed ID: 11100351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma.
    Sotiropoulos GC; Treckmann JW; Molmenti EP; Schmitz KJ; Cicinnati VR; Paul A; Broelsch CE; Malagó M
    Transpl Int; 2008 Feb; 21(2):182-5. PubMed ID: 17971034
    [No Abstract]   [Full Text] [Related]  

  • 16. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation.
    Wu L; Xu X; Shen J; Xie H; Yu S; Liang T; Wang W; Shen Y; Zhang M; Zheng S
    J Surg Oncol; 2007 Jul; 96(1):62-8. PubMed ID: 17443726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for hepatocellular carcinoma.
    McGahan JP
    J Am Coll Surg; 2004 May; 198(5):853-4; author reply 854-5. PubMed ID: 15110823
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic resections in the treatment of hepatocellular carcinoma].
    Partensky C
    Chirurgie; 1997; 122(8-9):463-7. PubMed ID: 9616889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
    Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
    J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.